February 08, 2024

Veritas In Silico Inc., Global Brain’s portfolio startup, is newly listed on TSE Growth Market

Veritas In Silico Inc. (Veritas In Silico), a company offering a platform for discovering mRNA-targeted small molecule drugs, is newly listed on the TSE Growth Market as of February 8, 2024. Global Brain invested in Veritas In Silico through its GB-VII Growth Fund Investment Limited Partnership and KDDI Open Innovation Fund III.

With the mission of building a society where every patient, especially those with diseases that currently have no satisfactory treatment, can look forward to a brighter future, Veritas In Silico has developed their ibVIS platform that combines informatics and experimental biology including in silico RNA structure analysis and has been conducting drug discovery research for mRNA-targeted small molecule drugs in collaboration with many pharmaceutical companies.

Global Brain will continue leveraging its resources to support portfolio startups in achieving significant growth.

The Global Brain mark is a registered trademark of Global Brain Corporation. Other marks and trade names are the property of their respective owners.